Quotient Wealth Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Quotient Wealth Partners’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-34,999	Closed	-$8.64K	–	426
2026 Q1	$8.64K	Hold	34,999	–	–	﹤0.01%	377
2025 Q4	$14.7K	Buy	+34,999	New	+$18.6K	﹤0.01%	352

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Quotient Wealth Partners's SGMO Position: Q2 2026 in Review

Quotient Wealth Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 34,999 shares — an estimated $8.64K sold.

Quotient Wealth Partners first reported a position in SGMO in Q4 2025 and held it in 2 quarters. The position peaked at $14.7K in Q4 2025. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Quotient Wealth Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Quotient Wealth Partners sold 34,999 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $8.64K.
Quotient Wealth Partners first reported a position in SANGAMO THERAPEUTICS INC in Q4 2025 and held it in 2 quarters.
Quotient Wealth Partners's SANGAMO THERAPEUTICS INC position peaked at $14.7K in Q4 2025.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.